Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus
- 20 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 72 (9), e215-e223
- https://doi.org/10.1093/cid/ciaa1014
Abstract
An increased risk of cardiovascular disease (CVD) was reported in patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV), without identifying factors associated with atherosclerotic CVD (ASCVD) events. HIV–HCV coinfected patients were enrolled in the ANRS CO13 HEPAVIH nationwide cohort. Primary outcome was total ASCVD events. Secondary outcomes were coronary and/or cerebral ASCVD events, and peripheral artery disease (PAD) ASCVD events. Incidences were estimated using the Aalen-Johansen method. Factors associated with ASCVD were identified using cause-specific Cox proportional hazards models. At baseline, median age of the study population (n=1213) was 45.4 (interquartile range [IQR] 42.1−49.0) years and 70.3% were men. After a median follow-up of 5.1 (IQR 3.9−7.0) years, the incidence was 6.98 (95% confidence interval [CI] 5.19−9.38) per 1000 person-years for total ASCVD events, 4.01 (2.78−6.00) for coronary and/or cerebral events, and 3.17 (2.05−4.92) for PAD ASCVD events. Aging (hazard ratio [HR] 1.06, 95% CI 1.01−1.12), prior CVD (HR 8.48, 95% CI 3.14−22.91), high total cholesterol (HR 1.43, 95% CI 1.11−1.83), high-density lipoprotein cholesterol (HR 0.22, 95% CI 0.08−0.63), statin use (HR 3.31, 95% CI 1.31−8.38), and high alcohol intake (HR 3.18, 95% CI 1.35−7.52) were independently associated with total ASCVD events, while undetectable baseline viral load (HR 0.41, 95%CI 0.18−0.96) with coronary and/or cerebral events. HIV–HCV coinfected patients experienced a high incidence of ASCVD events. Some traditional cardiovascular risk factors were the main determinants of ASCVD. Controlling cholesterol abnormalities and maintaining undetectable HIV viral load are essential to control cardiovascular risk.This publication has 40 references indexed in Scilit:
- HIV Infection and the Risk of Acute Myocardial InfarctionJAMA Internal Medicine, 2013
- HIV and Coronary Heart DiseaseJournal of the American College of Cardiology, 2013
- Arterial Inflammation in Patients With HIVJAMA, 2012
- Atherosclerosis risk in HIV-infected patients: The influence of hepatitis C virus co-infectionAtherosclerosis, 2012
- 2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS Key Data Elements and Definitions for Peripheral Atherosclerotic Vascular DiseaseCirculation, 2012
- The Risk of Incident Coronary Heart Disease Among Veterans With and Without HIV and Hepatitis CCirculation: Cardiovascular Quality and Outcomes, 2011
- Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patientsAIDS, 2010
- Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV‐infected patientsHIV Medicine, 2010
- The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individualsAIDS, 2007
- CD4+ Count–Guided Interruption of Antiretroviral TreatmentThe New England Journal of Medicine, 2006